Annual Drug Patent Expirations for DYMISTA
Dymista is a drug marketed by Mylan Speciality Lp and is included in one NDA. It is available from two suppliers. There are four patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for DYMISTA.
This drug has forty-eight patent family members in twenty-seven countries.
The generic ingredient in DYMISTA is azelastine hydrochloride; fluticasone propionate. Two suppliers are listed for this compound. Additional details are available on the azelastine hydrochloride; fluticasone propionate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com